TRANSFORM + Long-Term Follow-Up ASH 2025 Insights: Durability, Survival, and Safety Updates
| ASH 2025 - LBCL in Focus: Transforming Outcomes with CAR-T Therapy Panelists examine evolving second-line treatment strategies for relapsed/refractory large B-cell lymphoma, highlighting key trial updates, real-world evidence, and practical decision-making considerations. The discussion reviews long-term findings from the TRANSFORM and ZUMA-7 studies alongside emerging real-world data on CAR T utilization, outcomes, and access. |
|
|
Featured Video |
-Mar-12-2026-08-12-40-9375-PM.png?width=580&upscale=true&name=MarketingWS%20(1)-Mar-12-2026-08-12-40-9375-PM.png) |
| TRANSFORM + Long-Term Follow-Up ASH 2025 Insights: Durability, Survival, and Safety Updates Panelists discuss long-term outcomes from the TRANSFORM study evaluating liso-cel in second-line relapsed/refractory LBCL. |
|